搜尋結果
Medicare Says It Expects To Spend $3.5 Billion In 2025 On Alzheimer’s Drug Leqembi, But This Is ...
Forbes· 16 小時前Skepticism may be warranted when the Centers for Medicare and Medicaid Services’ Office of the ...
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
CNBC· 7 小時前Amgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data ...
Rescheduling Marijuana Won’t Reduce Regulatory Confusion On Drug’s Use
Forbes· 2 日前... is getting one step closer to rescheduling marijuana, according to The Hill. The Drug& ... ...
Weight-loss drug drives Eli Lilly to raise 2024 sales forecast by $2 billion
Reuters· 3 日前, opens new tab weight-loss drug Zepbound drove the company to raise its annual sales forecast ...
Inflammasome Therapeutics Announces First Patient Dosed in Geographic Atrophy (GA) Clinical Trial
Bastillepost· 4 日前The Phase 1 trial (ClinicalTrials.gov ID NCT06164587) is sponsored by the University of ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 21 小時前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 6 小時前, opens new tab said on Friday it had reached a deal valued at more than $270 million to ...
Royals run past Tigers 8-0
Bastillepost· 7 日前Demetrio Jackson was desperate for medical help when the paramedics arrived. Critics say its ...
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 4 日前California is stepping up efforts to combat surging opioid-related deaths by teaming with a ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 3 日前... Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous drug. ...